Search...
Features
Assets
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Arrowhead Pharmaceuticals (A2RR34.SA) Q1 2024 Earnings
A2RR34.SA
6
Feb
Confirmed
Q2 2023
Q3 2023
Q4 2023
Q1 2024
-9.42
-5.52
-1.63
2.27
Details
Expected EPS
-3.96984
Actual EPS
-6.153252
Surprise EPS
-2.18
Surprise Percent
+55%
Description
Arrowhead Pharmaceuticals (A2RR34.SA) has reported earnings of -6.153252 per share for Q1 2024.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login